4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-103807
SVP, Chief Accounting Officer sold 91 shares at $56.19 ($5,113)
From the SEC's structured data for this filing
Trades in this filing
Huizenga Theodore Alan · SVP, Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-03 | Sale : show line 1 in the form | −91 | $56.19 | $5,113 | 41,551 | D |
| Open-market sales · 91 sh · avg $56.19 · $5,113 | ||||||
Loading xslF345X05/ownership.xml…